ARTICLE | Company News
Syn X in stroke deal with Janssen
January 11, 2001 8:00 AM UTC
Janssen, a division of Johnson & Johnson (JNJ), will evaluate human stroke markers from Syn X (CDNX:SYY) in its animal models of stroke and traumatic brain injury. SYY will receive research payments. ...